Table 1 Baseline characteristics of the 6-month survivors ST-elevation myocardial infarction patients included in this registry

Patient characteristics

Total

(n = 423)

Men

(n = 319)

Women

(n = 104)

p-value

 Age (years)

63 ± 13.1

60.9 ± 12.7

69.2 ± 12.4

<0.001

 Current smokers

201 (47.9%)

173 (54.4%)

28 (27.5%)

<0.001

 Former smokers (>1 year)

100 (23.8%)

92 (28.9%)

8 (7.8%)

<0.001

 Hypertension

235 (55.5%)

165 (51.7%)

70 (67.3%)

<0.001

 Dyslipidemia

0.062

  Drug treatment

  No drug treatment

134 (32.5%)

73 (17.7%)

94 (30.3%)

62 (20%)

40 (39.2%)

11 (10.8%)

 Diabetes mellitus

112 (26%)

76 (24%)

36 (35%)

0.107

 Family history^a

39 (11%)

29 (10.5%)

10 (12.3%)

0.800

 Previous ischemic heart disease

44 (10.4%)

35 (11%)

9 (8.7%)

0.626

 Chronic kidney disease

14 (3.4%)

7 (2.3%)

7 (6.9%)

0.052

 Anemia

33 (8.2%)

19 (6.3%)

14 (14.1%)

0.023

AMI data

 Systolic blood pressure at admission (mmHg)

130 [114–150]

130 [112–148]

140 [120–164]

0.003

 Infarct location

0.713

  Anterior

151 (35.7%)

112 (35.1%)

39 (37.5%)

  Inferior

231 (54.6%)

178 (55.8%)

53 (51%)

 Killip class

0.137

  I

341 (83.2%)

264 (84.9%)

77 (77.8%)

  II

35 (8.1%)

22 (7.1%)

11 (11.1%)

  III

16 (3.9%)

9 (2.9%)

7 (7.1%)

  IV

21 (4.9%)

16 (5.1%)

4 (4.1%)

 LVEF

52.1 ± 12

52,5 ± 12

51 ± 12

0.283

Blood test at admission

Total

(n = 423)

Men

(n = 319)

Women

(n = 104)

p-value

 Hb (gr/dL)

14 ± 1.8

14.4 ± 1.7

12.9 ± 1.7

<0.001

 GFR (mL/min/m2)

60 [60–60]

60 [60–60]

60 [60–60]

0.006

 Basal glucose (mg/dL)

111 [98–136]

110 [98–133]

114 [97–148]

0.423

 HbA1c (%) (in DM)

7.25 [6.60–8.53]

7.30 [6.60–8.53]

7.10 [6.60–8.08]

0.643

 Total Cholesterol (mg/dL)

183 [150–214]

182 [151–212]

188 [150–219]

0.425

 LDL-Cholesterol (mg/dL)

112 [84–139]

112 [85–138]

112 [82–142]

0.842

 HDL-Cholesterol (mg/dL)

44 [37–53]

42 [36–50]

49 [41–60]

<0.001

 Triglycerides (mg/dL)

120 [88–168]

124 [91–173]

112 [80–159]

0.061